论文信息 - ECMO therapy in COVID‐19: An experience from Zurich

ECMO therapy in COVID‐19: An experience from Zurich

The current coronavirus disease 2019 (COVID‐19) pandemic has a huge impact on society and the economy and represents one of the biggest challenges for healthcare systems all over the world. Reports from healthcare institutions in different countries show a variety of crisis exit strategies.

F. Maisano | C. Mestres | M. Schmiady | J. Sromicki

[1] N. Kucher,et al. Successful percutaneous thrombectomy in a patient with COVID-19 pneumonia and acute pulmonary embolism supported by extracorporeal membrane oxygenation , 2020, European heart journal.

[2] M. Taramasso,et al. The Certificate of Advanced Studies (CAS) course adapted to a pandemic , 2020, European Heart Journal.

[3] M. Salathé,et al. COVID-19 epidemic in Switzerland: on the importance of testing, contact tracing and isolation. , 2020, Swiss medical weekly.

[4] F. Ruschitzka,et al. Outcome of inter-hospital transfer of patients on extracorporeal membrane oxygenation in Switzerland. , 2019, Swiss medical weekly.

[5] L. Dean,et al. Conscious sedation for TAVR: A wave of the future? , 2018, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[6] Y. Arabi,et al. Extracorporeal membrane oxygenation for severe Middle East respiratory syndrome coronavirus , 2018, Annals of Intensive Care.

[7] Susanna Price,et al. Referral to an extracorporeal membrane oxygenation center and mortality among patients with severe 2009 influenza A(H1N1). , 2011, JAMA.

[8] D. Français,et al. Federal Office of Public Health FOPH , 2013 .

[9] Beit Jala,et al. Bevölkerung , 2005, Humanökologie.